BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koch TR, Petro A, Darrabie M, Opara EC. Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy. Dig Dis Sci 2005;50:86-93. [PMID: 15712643 DOI: 10.1007/s10620-005-1283-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Yadav SK, Adhikary B, Bandyopadhyay SK, Chattopadhyay S. Inhibition of TNF-α, and NF-κB and JNK pathways accounts for the prophylactic action of the natural phenolic, allylpyrocatechol against indomethacin gastropathy. Biochim Biophys Acta. 2013;1830:3776-3786. [PMID: 23523691 DOI: 10.1016/j.bbagen.2013.03.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
2 Mckeage K, Blick SKA, Croxtall JD, Lyseng-williamson KA, Keating GM. Esomeprazole: A Review of its Use in the Management of Gastric Acid-Related Diseases in Adults. Drugs 2008;68:1571-607. [DOI: 10.2165/00003495-200868110-00009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
3 Yoneyama K, Koshida Y, Toriumi F, Murayama T, Toeda H, Imazu Y, Motegi K, Akamatsu H, Ohyama R. [A case of postoperative pulmonary metastasis of breast cancer treated with docetaxel and cyclophosphamide therapy]. Gan To Kagaku Ryoho 2006;33:227-9. [PMID: 16484861 DOI: 10.2217/14750708.3.2.227] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Chakraborty S, Yadav SK, Saha B, Tyagi M, Singh Rathee J, Chattopadhyay S. A bis-resorcinol resveratrol congener prevents indomethacin-induced gastric ulceration by inhibiting TNF-α as well as NF-κB and JNK pathways. Free Radical Research 2019;53:596-610. [DOI: 10.1080/10715762.2019.1572887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Brudvik KW, Paulsen JE, Aandahl EM, Roald B, Taskén K. Protein kinase A antagonist inhibits β-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice. Mol Cancer 2011;10:149. [PMID: 22168384 DOI: 10.1186/1476-4598-10-149] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
6 Blandizzi C, Tuccori M, Colucci R, Gori G, Fornai M, Antonioli L, Ghisu N, Del Tacca M. Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patients. Drugs Aging. 2008;25:197-208. [PMID: 18331072 DOI: 10.2165/00002512-200825030-00003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
7 Bal B, Koch TR, Finelli FC, Sarr MG. Managing medical and surgical disorders after divided Roux-en-Y gastric bypass surgery. Nat Rev Gastroenterol Hepatol. 2010;7:320-334. [PMID: 20458335 DOI: 10.1038/nrgastro.2010.60] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
8 Pastoris O, Verri M, Boschi F, Kastsiuchenka O, Balestra B, Pace F, Tonini M, Natale G. Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin. Naunyn Schmiedebergs Arch Pharmacol. 2008;378:421-429. [PMID: 18545984 DOI: 10.1007/s00210-008-0314-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
9 Shiomi M, Takada T, Tanaka Y, Yajima K, Isomoto A, Sakamoto M, Otori K. Clinical factors associated with the occurrence of nausea and vomiting in type 2 diabetes patients treated with glucagon-like peptide-1 receptor agonists. J Diabetes Investig 2019;10:408-17. [PMID: 30033675 DOI: 10.1111/jdi.12900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Colucci R, Fornai M, Antonioli L, Ghisu N, Tuccori M, Blandizzi C, Del Tacca M. Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment. Digestive and Liver Disease 2009;41:395-405. [DOI: 10.1016/j.dld.2008.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]